Dishman Carbogen Amcis informs about credit rating

22 Dec 2022 Evaluate
Dishman Carbogen Amcis has informed that India Ratings & Research ('Ind-Ra') has affirmed the Company's Rating for long term credit facilities at 'IND A+', for short term credit facilities at 'IND A1+', and assigned Rating for Proposed non-convertible debentures/term loan at 'IND A+’ with a 'Stable' outlook. Since the company did not proceed with the commercial paper instrument as envisaged, based upon company's request, it has withdrawn Rating for this instrument. Details of instrument wise rating are mentioned in the attached file.

The above information is a part of company’s filings submitted to BSE.

Dishman Carbogen Amc Share Price

162.10 -25.30 (-13.50%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.